Results 21 to 30 of about 2,415 (174)

Synergistic neurotrophic effects of piracetam and thiotriazoline

Неврология, нейропсихиатрия, психосоматика, 2016
The paper considers the synergy between the nootropic drug piracetam and the metabolic agent thiotriazoline that maintains energy metabolism and survival of neurons and other types of cells. Piracetam, a nootropic drug, a chemical pyrrolidone derivative,
O. A. Gromova, I. Yu. Torshin, A. V. Pronin, A. Yu. Volkov   +3 more
doaj   +1 more source

Hepatic encephalopathy complications are diminished by piracetam via the interaction between mitochondrial function, oxidative stress, inflammatory response, and locomotor activity

Heliyon, 2023
Background: of the study: Hepatic encephalopathy (HE) is a complication in which brain ammonia (NH4+) levels reach critically high concentrations because of liver failure.
Hossein Niknahad, Ali Mobasheri, Abdollah Arjmand, Elahe Rafiei, Sepideh Alidaee, Hadi Razavi, Sara Bagheri, Heresh Rezaei, Samira Sabouri, Asma Najibi, Forouzan Khodaei, Seyyed Mohammad Amin Kashani, Mohammad Mehdi Ommati, Reza Heidari   +13 more
doaj   +1 more source

Long term effects of piracetam on spectral analysis of EEG in Alzheimer’s disease and minimal cognit›ve impairment

Psychiatry and Clinical Psychopharmacology, 2021
Objective: Influence of piracetam in post-stroke aphasia and myoclonic epilepsy has been shown with EEG spectral power analysis. Particularly piracetam is involved in restoration of alpha topography in these patients. On the other hand long term effects
Eylem Degirmenci, Türker Şahiner, Çağdaş Erdogan, Fatma Özdemir, Selahattin Gür, Melike Şahiner   +5 more
doaj  

The influence of Piracetam and Phenotropil on brain dopamine and serotonin metabolism in CD-1 mice sub-populations, diverging in attention sustainability

Фармакокинетика и Фармакодинамика, 2022
The effect of subchronic administration of the nootropics Phenotropil (100 mg/kg/day) on the behavior of CD-1 outbreed mice in the "closed enriched cross maze" test (CECM) was studied.
N. A. Sukhorukova, V. S. Kudrin, V. B. Narkevich, G. I. Kovalev   +3 more
doaj   +1 more source

A comparative evaluation of neuroprotective activity of perindopril and valsartan in rats

National Journal of Physiology, Pharmacy and Pharmacology, 2022
Background: Angiotensin II receptor blockers and Angiotensin-converting enzyme inhibitors are widely used drugs for cardiovascular disorders, renal disease, and diabetes.
Pratiksha Vijaysinh Dhamal, Vijay Haribhau Mate   +1 more
doaj   +1 more source

„Cognitive Enhancement" or non-evidence-based nootropic abuse? – Use of Piracetam in Hungary

Cardiologia Hungarica
Piracetam has been available on the market since 1971. Its primary indication is the age-related memory decline. The objective of this review is to highlight the controversies surrounding in the use of piracetam.
András Érszegi, Máté Vámos, Réka Viola, Dezső Csupor, Anna Vágvölgyi   +4 more
doaj   +1 more source

Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.

PLoS ONE, 2013
BackgroundNumerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on age-related cognitive decline often leading to inconclusive results due to small ...
Hélène Amieva, Céline Meillon, Catherine Helmer, Pascale Barberger-Gateau, Jean François Dartigues   +4 more
doaj   +1 more source

Effects of parenteral papaverine and piracetam administration on cochlea following acoustic trauma

Noise and Health, 2018
Introduction: Noise exposure, the main cause of hearing loss in countries with lot of industries, may result both in temporary or permanent hearing loss.
Nurcan Yurtsever Kum, Yavuz F Yilmaz, Seren G Gurgen, Rauf O Kum, Muge Ozcan, Adnan Unal   +5 more
doaj   +1 more source

Piracetam as a Therapeutic Agent for Doxorubicin-Induced Cognitive Deficits by Enhancing Cholinergic Functions and Reducing Neuronal Inflammation, Apoptosis, and Oxidative Stress in Rats

Pharmaceuticals, 2022
Cancer chemotherapy is known to cause cognitive defects in patients. Our study investigated the effect of piracetam (PIRA; 200 or 400 mg/kg) against doxorubicin (DOX)-induced cognitive deficits in a rat model. The cognitive parameters were analyzed using
Vasudevan Mani, Syed Imam Rabbani, Ali Shariq, Palanisamy Amirthalingam, Minhajul Arfeen   +4 more
doaj   +1 more source

Neurobehavioral Impacts of Xylazine and Piracetam Interaction on NADH Oxidase in the Rat Brain

Kufa Journal for Veterinary Medical Sciences
      In the present study, the effects of different doses of xylazine combined with piracetam were investigated through different behavioral experiments. Xylazine is alpha 2 adrenergic agonist a veterinary sedative, and analgesic agent.
Shaker M. Kermasha, Mohammad T. Naqi Al-Bayati   +1 more
doaj   +1 more source